| Q73341608 | A gift of life: umbilical cord blood |
| Q36363237 | Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood |
| Q26824305 | Advances in umbilical cord blood manipulation-from niche to bedside |
| Q71897459 | Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease |
| Q33769696 | Allogeneic transplantation from donors other than HLA-identical siblings |
| Q47614526 | Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease. |
| Q38515161 | An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment |
| Q72096865 | Aspects of the biology of the neonatal hematopoietic stem cell |
| Q44606441 | Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation |
| Q57808539 | Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment |
| Q37443125 | Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns |
| Q36235319 | Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox |
| Q72548877 | Bone marrow transplantation: critical care implications |
| Q57589522 | Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle |
| Q53563033 | Circulating stem cells in extremely preterm neonates. |
| Q53653909 | Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells. |
| Q71948166 | Comparison of hematopoietic progenitor cells in human umbilical cord blood collected from neonatal infants who are small and appropriate for gestational age |
| Q50788309 | Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice. |
| Q37255041 | Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine |
| Q38142167 | Cord Blood Transplantation: Can We Make it Better? |
| Q38690849 | Cord blood as a potential therapeutic for amyotrophic lateral sclerosis |
| Q37607968 | Cord blood banking for clinical transplantation |
| Q43147648 | Cord blood banking: what are the real issues? |
| Q64968638 | Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. |
| Q36671440 | Cord blood stem and progenitor cells |
| Q37096984 | Cord blood stem cell transplantation for haemoglobinopathies |
| Q45876292 | Cord blood transplantation and the potential for gene therapy. Gene transduction using a recombinant adeno-associated viral vector. |
| Q38780874 | Cord blood transplantation: rewind to fast forward |
| Q74554537 | Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms |
| Q71950560 | Cord-Blood-Cell Transplantation — A Real Sleeper? |
| Q27012935 | Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation |
| Q44352994 | Cryopreservation of umbilical cord blood: 2. Tolerance of CD34(+) cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing |
| Q35551439 | Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy |
| Q36823321 | Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis |
| Q53535911 | Early proliferation of umbilical cord blood cells from premature neonates. |
| Q36192813 | Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function |
| Q36984624 | Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation |
| Q47970956 | Erythropoietin in umbilical cord blood transplantation: defining the role and implications |
| Q46810847 | Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation. |
| Q54502510 | Escherichia coli up-regulates proinflammatory cytokine expression in granulocyte/macrophage lineages of CD34 stem cells via p50 homodimeric NF-kappaB. |
| Q28391247 | Evaluation of potential ionizing irradiation protectors and mitigators using clonogenic survival of human umbilical cord blood hematopoietic progenitor cells |
| Q60313657 | Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood |
| Q34724924 | Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. |
| Q38994507 | Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood |
| Q37607979 | Ex vivo expansion of cord blood |
| Q47686617 | Ex vivo expansion of cord blood progenitors |
| Q38561480 | Ex vivo expansion of hematopoietic stem cells |
| Q48208884 | Ex vivo expansion of human umbilical cord blood CD34+ cells in a collagen bead-containing 3-dimensional culture system |
| Q37788414 | Ex vivo expansion of umbilical cord blood for transplantation |
| Q72096823 | Expansion of cord blood progenitors and use for hemopoietic reconstitution |
| Q33504681 | Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure |
| Q53281888 | Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro. |
| Q36267781 | Genetic engineering: moral aspects and control of practice |
| Q40505311 | Growth factors and cord blood stem and progenitor cells |
| Q35256009 | Hematopoietic stem and progenitor cell trafficking |
| Q35674530 | Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results |
| Q40505347 | Hematopoietic stem cells: "form--method--characteristics". |
| Q35001593 | Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood |
| Q55101110 | Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice. |
| Q36234949 | Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. |
| Q36362618 | High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood |
| Q34470409 | High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years |
| Q57808603 | High-efficiency volume reduction of cord blood using pentastarch |
| Q37607988 | History of cord blood transplantation |
| Q71649118 | Human Umbilical Cord Blood CD34+Cell Purification with High Yield of Early Progenitors |
| Q37353891 | Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction |
| Q41279148 | Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice |
| Q36362150 | Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease |
| Q35625454 | Human umbilical cord blood (HUCB) cells for central nervous system repair |
| Q33892749 | Human umbilical cord blood banking and transplantation: a state of the art. |
| Q37517949 | Human umbilical cord blood cell grafts for brain ischemia |
| Q40963674 | Human umbilical cord blood for hematopoietic progenitor cells transplantation |
| Q47309435 | Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size |
| Q24670352 | Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning |
| Q36666422 | Immunological applications of stem cells in type 1 diabetes |
| Q36365582 | Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes |
| Q43855429 | Improvement of combination chemotherapy tolerance by introduction of polycistronic retroviral vector drug resistance genes MGMT and MDR1 into human umbilical cord blood CD34+ cells |
| Q90565724 | In Response to "Use of autologous umbilical cord blood transfusion in neonates undergoing surgical correction of congenital cardiac defects: A pilot study" |
| Q37863720 | Insights into the biology of cord blood stem/progenitor cells |
| Q34719998 | Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. |
| Q39816447 | Isolation and Culture of Porcine Adipose Tissue-Derived Somatic Stem Cells |
| Q35690280 | Isolation of dendritic cells from umbilical cord blood using magnetic activated cell sorting or adherence |
| Q44006781 | MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells |
| Q37296284 | Mankind's first natural stem cell transplant. |
| Q37247846 | Mesenchymal stem cells in ex vivo cord blood expansion |
| Q47104523 | Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia |
| Q48636372 | Milestones in umbilical cord blood transplantation |
| Q37317728 | Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center |
| Q42830771 | Modified in vitro conditions for cord blood-derived long-term culture-initiating cells. |
| Q28732245 | Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS |
| Q41985161 | Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells |
| Q36626146 | Novel cell therapy approaches for brain repair |
| Q36362285 | Ontogeny-related changes in proliferative potential of human hematopoietic cells |
| Q33252501 | Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells |
| Q42974699 | Overcoming the barriers to umbilical cord blood transplantation |
| Q74813033 | Phenotypic characteristics of cord blood hemopoietic cells |
| Q58597983 | Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseases |
| Q73388222 | Postpartum umbilical cord blood collection for transplantation: a comparison of three methods |
| Q35840586 | Potency analysis of cellular therapies: the emerging role of molecular assays |
| Q72046311 | Probability of progenitor renewal (PPR) and production of clonogenic progeny (CFU‐GM) by primitive adherent progenitor cells in adult human bone marrow and umbilical cord blood |
| Q33819877 | Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution |
| Q44366709 | Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide |
| Q40493946 | Progress in the ex vivo expansion of hematopoietic progenitors. |
| Q37683269 | Quality of cord blood cryopreserved for up to 5 years |
| Q58415085 | Quantitative and Qualitative Immune Reconstitution Following Umbilical Cord Blood Transplantation |
| Q41279525 | Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells. |
| Q36548234 | Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults |
| Q54194578 | Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells. |
| Q44083065 | SDF-1alpha/CXCL12 enhances retroviral-mediated gene transfer into immature subsets of human and murine hematopoietic progenitor cells |
| Q71649109 | Separation of Hematopoietic Progenitor Cells from Human Umbilical Cord Blood |
| Q72105926 | Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood |
| Q42126220 | Stem cell technology. Interview by Abi Berger |
| Q34111059 | Strategies to enhance umbilical cord blood stem cell engraftment in adult patients |
| Q73316429 | Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells |
| Q42160266 | Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells |
| Q92561161 | Thawing methods do not affect cell viability of CD45+ and CD34+ cells, but long-term cryopreservation of umbilical cord blood units generally decreases cell viability |
| Q33464242 | The Belfast Cord Blood Bank |
| Q33383968 | The construction of an in vitro three-dimensional hematopoietic microenvironment for mouse bone marrow cells employing porous carriers |
| Q53297834 | The effects of human umbilical cord blood transplantation in rats with experimentally induced spinal cord injury |
| Q40517931 | The role of hematopoietic growth factors in transfusion medicine. |
| Q37543431 | The role of oral beclometasone dipropionate in the treatment of gastrointestinal Graft-versus-Host Disease |
| Q34032567 | The switch from fetal to adult erythropoiesis |
| Q43875695 | Thymus-independent T-cell differentiation in vitro |
| Q96949181 | Total nucleated cell counts are driving clinician's choice rather than cryopreservation period: Lesson for cord blood banks |
| Q42742576 | Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12 |
| Q44473182 | Transfusional perspectives for ex vivo control of hematopoiesis |
| Q35681487 | Transplantation of human umbilical cord blood cells in the repair of CNS diseases |
| Q37763613 | Transplantation of umbilical cord blood stem cells for treating spinal cord injury |
| Q44903785 | Umbilical Cord Blood Stem Cell Transplantation |
| Q36808858 | Umbilical cord blood research: current and future perspectives |
| Q41470967 | Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies |
| Q33634109 | Umbilical cord blood transplantation |
| Q36746512 | Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications |
| Q34344669 | Umbilical cord blood transplantation: the first 25 years and beyond |
| Q36167454 | Umbilical cord blood-derived stem cells and brain repair. |
| Q40743064 | Umbilical cord blood: an expandable resource |
| Q37810269 | Umbilical cord blood: biology and transplantation |
| Q39635182 | Umbilical cord matrix derived mesenchymal stem cells can change the cord blood transplant scenario. |
| Q35166819 | Umbilical-cord blood transplantation for the treatment of cancer |
| Q43636008 | Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium |
| Q30410059 | Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells |